The federal push to let autonomous AI diagnose patients and prescribe drugs is setting up a dangerous collision between political speed and medical safety.
Standard genetic tests miss the complex networks of DNA variants that cause multiple diseases in the same family, but a new topological AI approach could change how we find them.
A new multi-task AI model predicts two critical gastric cancer immunotherapy biomarkers from routine biopsy slides, but its real-world drop in accuracy highlights a persistent industry bottleneck.